Healios K.K. ( HLOSF) - Key Metrics
HLOSF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.05 | $8.77 | -$9.15 | -$9.85 |
| 2026Q1 | $0.06 | -$27.82 | -$10.16 | -$10.45 |
| 2025Q4 | $0.25 | $18.91 | -$8.21 | -$9.13 |
| 2025Q3 | $0.17 | $4.95 | -$6.59 | -$7.10 |
| 2025Q2 | $0.21 | -$20.57 | -$7.81 | -$7.85 |
HLOSF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 8.34 |
| 2026Q1 | 0% | -3.21 |
| 2025Q4 | 0% | 4.02 |
| 2025Q3 | 0% | 30.98 |
| 2025Q2 | 0% | -5.69 |
HLOSF
Price: $1.80
52 week price:
Earnings Per Share: 0.01 USD
P/E Ratio: 180
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 243.0 million